Neurological and inflammatory biomarkers in CSF along the Alzheimer's Disease spectrum

Abstract

Background: Alzheimer's disease (AD) is a heterogeneous neurodegenerative disease with a decades‐long prodromal period. Monitoring of sequential pathological changes in neurodegeneration, inflammation, neurovascular dysfunction, oxidative stress and metabolic stress may provide the opportunity for intervention before symptom onset.